Susquehanna International Group
COYA icon

Susquehanna International Group’s Coya Therapeutics COYA Stock Holding History

Susquehanna International Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Sell
39,316
-85,515
-69% -$400K ﹤0.01% 11963
2025
Q4 		$724K Buy
124,831
+91,476
+274% +$556K ﹤0.01% 7949
2025
Q3 		$190K Sell
33,355
-16,795
-33% -$102K ﹤0.01% 11048
2025
Q2 		$288K Sell
50,150
-8,832
-15% -$51.2K ﹤0.01% 10430
2025
Q1 		$382K Buy
58,982
+28,247
+92% +$179K ﹤0.01% 9513
2024
Q4 		$176K Buy
+30,735
New +$209K ﹤0.01% 10865

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's COYA Position: Q1 2026 in Review

Susquehanna International Group reduced its Coya Therapeutics (COYA) stake by 69% in Q1 2026, selling an estimated $400K and leaving 39,316 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #11963.

Susquehanna International Group first reported a position in COYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $724K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Susquehanna International Group held 39,316 shares of Coya Therapeutics worth $155K as of Q1 2026.
  • Susquehanna International Group sold 85,515 Coya Therapeutics shares in Q1 2026, an estimated $400K.
  • Coya Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11963 holding.
  • Susquehanna International Group first reported a position in Coya Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Susquehanna International Group's Coya Therapeutics position peaked at $724K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.